test

Ryan Cappelli

@Prosight Management, Lp

Latest period2024 - Q3ReportedManaged Assets$406.357MTotal holdings45
Assets growth rate21.46%Assets growth rate (2-Q avg)7.27%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Prosight Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Prosight Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 406.357M in assets, with a quarterly growth rate of 21.46% and a 2-quarter average growth rate of 7.27%. The portfolio is managed by Ryan Cappelli, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KURAKura Oncology Inc
Recent Activity
Increased 11.94%
3.4%
$13.778M
705,109 shares@ $19.55 avg price
SDGRSchrodinger Inc
Recent Activity
Increased 89.57%
3.2%
$12.985M
700,000 shares@ $18.55 avg price
ZYMEZymeworks Inc
Recent Activity
Decreased -22.23%
2.84%
$11.516M
917,599 shares@ $12.55 avg price
ACCDAccolade Inc
Recent Activity
Increased 88.09%
2.66%
$10.786M
2.802M shares@ $3.85 avg price
DXCMDexcom Inc
Recent Activity
Increased 224.44%
2.64%
$10.726M
160,000 shares@ $67.04 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 0.47%
2.63%
$10.666M
554,103 shares@ $19.26 avg price
IMVTImmunovant Inc
Recent Activity
Increased 13.85%
2.6%
$10.549M
370,000 shares@ $28.51 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -16.21%
2.51%
$10.175M
192,700 shares@ $52.8 avg price
JANXJanux Therapeutics Inc
Recent Activity
New Position
2.3%
$9.313M
205,000 shares@ $45.43 avg price
PRTAProthena Corp Plc
Recent Activity
Increased 68.5%
2%
$8.088M
483,467 shares@ $16.74 avg price